Rapid response of cutaneous lupus erythematosus to treatment with the type I interferon receptor antagonist anifrolumab. Gunther C. Br J Dermatol 2023 Apr 1:ljad111. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gunther C. Rapid response of cutaneous lupus erythematosus to treatment with the type I interferon receptor antagonist anifrolumab. Br J Dermatol 2023 Apr 1:ljad111. doi: 10.1093.
PMID: 37002783